首页 | 本学科首页   官方微博 | 高级检索  
     


Synthesis and evaluation of 18F-labeled tertiary benzenesulfonamides for imaging carbonic anhydrase IX expression in tumours with positron emission tomography
Affiliation:1. Department of Neuroradiology, Eberhard Karls University Tübingen, Hoppe-Seyler-Str. 3, Tübingen 72076, Germany;2. Department of Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany;3. Department of Internal Medicine—Oncology, Eberhard Karls University Tübingen, Tübingen, Germany;1. Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands;2. Stratingh Institute for Chemistry, University of Groningen, Groningen, the Netherlands
Abstract:Three tertiary benzenesulfonamide inhibitors 4ac were radiolabeled with 18F and evaluated for imaging carbonic anhydrase IX (CA IX) expression with positron emission tomography. All three inhibitors exhibit <10 nM affinity for CA IX with no measurable affinity for CA II. Despite good affinity/selectivity to CA IX and excellent stability in plasma, uptake of [18F]4ac in CA IX-expressing HT-29 tumours was low without significant contrast. [18F]4a,b were excreted rapidly, while [18F]4c exhibited significant in vivo defluorination leading to high bone uptake. Due to minimal uptake in HT-29 tumours compared to normal organs/tissues, 18F-labeled benzenesulfonamides [18F]4ac are not suitable as CA IX imaging agents.
Keywords:Carbonic anhydrase IX  Tertiary benzenesulfonamides  Fluorine-18  In vivo defluorination  Positron emission tomography
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号